Evidence map›Paper›PMID 39150972›Full record

ArticlePloS one2024

The application and implications of science and technology innovation in the management of education for Chinese students studying abroad in China in the epidemic era.

Tiejun Zhu, Mengzhen Gu

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tiejun ZhuInstitute of International Education, Anhui Polytechnic University, Wuhu, Anhui, China.ORCID 0000-0002-8628-6710
Mengzhen GuSchool of Design, Anhui Polytechnic University, Wuhu, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough COVID-19 has brought serious disasters to all mankind, it has also accelerated the innovation and application of educational science and technology. China is the first to bear in COVID-19, and in order to minimize the impact of the field of education and teaching involving a large number of students, educational technology has entered a stage of continuous innovation and large-scale application, especially in higher education institutions. PURPOSE: Firstly, it introduces the progress and achievements of China's educational science and technology innovation during the COVID-19 epidemic, as well as the in-depth application of it in education for studying abroad in China. Secondly, the problems and gaps of STI in education for studying abroad in China are analyzed. Once again, it puts forward the solution countermeasures and future development strategies for the science and technology innovation of education abroad in China.

methodsA cross-sectional survey of 258 international students from 20 universities was conducted using a self-administered questionnaire entitled "Research on Innovation and Application of Science and Technology in China's International Education under the Situation of Conventional COVID-19 Epidemic Prevention and Control".

resultsIt will put forward opinions and suggestions to promote the deepening and improvement of China's education science and technology innovation and application, as well as to provide a commentary and theoretical contribution to similar issues and phenomena around the world.

conclusionThrough in-depth research and analysis, it is found that the application of science, technology and innovation has played a great role in China's study abroad education, which not only improves the quality and effect of teaching, but also enriches the means and methods of teaching.

Indexed as

Educational TechnologyScienceStudentsTechnologyChinaCOVID-19Cross-Sectional StudiesEast Asian PeopleFemaleHumansInventionsMaleSurveys and QuestionnairesUniversitiesYoung Adult

Identifiers

PMID39150972
PMCPMC11329156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.